Applications of Methyl 3,5-Dihydroxyphenylacetate in Industrial Manufacturing

Methyl 3,5-Dihydroxyphenylacetate supports several key manufacturing sectors as a specialty aromatic intermediate. As an original manufacturer, we supply this compound to established clients in pharmaceutical synthesis, advanced polymer additives, flavor and fragrance bases, and specialty fine chemicals, where its physicochemical attributes align with industry-specific standards and performance demands.

1. Pharmaceutical Intermediate for Active Pharmaceutical Ingredients (APIs)

Methyl 3,5-Dihydroxyphenylacetate serves as a critical phenolic intermediate in the synthesis of select non-steroidal anti-inflammatory drugs (NSAIDs) and other phenylacetate-structured pharmaceuticals. Drug manufacturers incorporate this material in multi-step organic syntheses where control of hydroxylation patterns can influence target activity, purity profiles, and regulatory approval. Production plants typically adjust input ratios based on each batch’s stoichiometric requirements, maintaining adherence to pharmacopeial monographs and cleanroom GMPs. End products proceed to further downstream purification before tableting or encapsulation.

Industry compliance standards

• ICH Q7 Good Manufacturing Practice for Active Pharmaceutical Ingredients
• USP / EP / JP Pharmacopoeia Monographs for API intermediates
• CFR Title 21 (FDA, US) for pharmaceutical raw materials
• ISO 9001 certified quality systems for manufacturer audits

Typical usage ratio

• 0.7 – 1.2 molar equivalents relative to key coupling reactants; adjusted per synthesis scheme and targeted yield/purity (weight percent variable, typically 4 – 8%)

Downstream process integration

• Charge during amidation or esterification stages under controlled temperature and inert atmosphere
• Incorporate as phenolic coupling agent in Grignard and Suzuki syntheses
• Used in continuous reactor setups for large-scale pharmaceutical plants

Final product types

• Non-steroidal anti-inflammatory drugs (NSAIDs)
• Antibacterial pharmaceutical APIs
• API intermediates for cardiovascular and neurology drug candidates
• Bulk pharmaceutical chemicals for GMP-compliant finishing

2. High-Performance Polyurethane Additives

Methyl 3,5-Dihydroxyphenylacetate is incorporated into specialty polyol formulations for rigid and flexible polyurethane systems, where aromatic backbone and multiple hydroxyl groups enhance thermal stability and flame retardancy of finished polymers. The additive is particularly valued in foam and elastomer segments demanding precise rheological control without altering key mechanical characteristics. Large formulators dose this intermediate based on final density and crosslinking targets, often running batch validations to confirm compatibility with isocyanates and secondary fillers.

Industry compliance standards

• ISO 4589-2 (Determination of flammability of plastics by oxygen index)
• REACH Regulation (EC) No 1907/2006 for chemical registration
• EN 71-3 (Safety of toys: migration of certain elements) for foam in consumer goods
• UL 94 (Flammability for plastic materials)

Typical usage ratio

• 0.5 – 1.5% w/w as a co-polyol additive, based on total polyol content; optimized per flame retardant and hardness requirements

Downstream process integration

• Preshot blending with polyols prior to addition of isocyanate in PU foam lines
• Metered addition in extruder lines during elastomer compounding
• Inline QC sampling for hydroxyl value and viscosity adjustment

Final product types

• Low-flammability rigid PU foams for insulation panels
• Flexible PU foams for automotive seating
• PU elastomers for industrial rollers
• Fire-retardant PU component parts in electronics

3. Flavor and Fragrance Ester Precursor

This intermediate finds genuine use in the synthesis of musk-related and complex aromatic notes for flavor and fragrance houses. It is valued for its dual hydroxyl groups that enable branching into layered ester or ether top notes, providing formulation stability and nuanced aroma profiles. Regulatory restrictions on impurities and trace solvents necessitate high-purity supplies from original manufacturers. Processors optimize dosage for target compound intensity, factoring in compatibility with essential oils and regulatory residue thresholds in consumer products.

Industry compliance standards

• IFRA Code of Practice (International Fragrance Association)
• EU Regulation (EC) No 1223/2009 on Cosmetic Products
• US FEMA GRAS (Flavor and Extract Manufacturers Association Generally Recognized As Safe)
• ISO 9001 for batch traceability

Typical usage ratio

• 0.1 – 0.8% by mass in fragrance bases, depending on compound intensity and total aroma profile
• 0.02 – 0.15% in food flavor compounds; benchmarked by end-use applications (e.g. beverages vs. confectionery)

Downstream process integration

• Joined into esterification or transesterification reactions with fatty alcohols for fragrance notes
• Reacted with aldehydes for musk base synthesis in stirred reactor vessels
• Emulsified in solution for spray-dried flavor granules

Final product types

• Luxury perfume base compounds
• Specialty flavor concentrates for beverages
• Processed aroma additives for packaged foods
• Air care and home fragrance diffusers

4. Specialty Fine Chemicals Synthesis

Chemical manufacturers utilize Methyl 3,5-Dihydroxyphenylacetate as a building block for producing advanced fine chemicals involved in agrochemical, dye, and specialty coating formulations. Its bifunctional groups enable efficient coupling and etherification routes, particularly when preparing complex aromatic scaffolds or high-performance pigments. Integration into reaction trains is carefully controlled under cGMP or ISO-guided protocols to minimize byproduct formation and maximize target selectivity. Dosage levels reflect the reactivity and desired branching density in each tailored compound.

Industry compliance standards

• ISO 9001:2015 Quality Management Systems
• GMP guidelines for fine chemical intermediates (where applicable)
• EU CLP Regulation (EC) No 1272/2008 for classification and labelling
• OECD Good Laboratory Practice (GLP) for process development

Typical usage ratio

• 1.0 – 5.0% by mass, selected according to branching and aromatic content targets of the final specialty compound

Downstream process integration

• Loaded as a core aromatic scaffold during multi-step coupling reactions
• Subjected to etherification or halogenation steps for specialty pigment conversion
• Utilized in semi-continuous flow reactors with online quality monitoring

Final product types

• Intermediate building blocks for advanced agrochemicals
• High-stability organic pigments for coatings and inks
• Monomer precursors for electronic and optical polymers
• Photostable colorants for specialty paints